Clinical Pharmacology and the Catalysis of Regulatory Science: Opportunities for the Advancement of Drug Development and Evaluation

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|93|6|515-525

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.93, Iss.6, 2013-06, pp. : 515-525

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transporters in Drug Development and Clinical Pharmacology

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 1, 2013-07 ,pp. : 3-9

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of Federal Regulatory Changes on Clinical Pharmacology and Drug Development: the Common Rule and the 21st Century Cures Act

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 58, Iss. 3, 2018-03 ,pp. : 281-285

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical pharmacology, creating current and future success in drug development

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 91-2700, Iss. 11, 2015-11 ,pp. : 1193-1197

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical pharmacology, creating current and future success in drug development

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 11, 2015-11 ,pp. : 1193-1197

John Wiley & Sons Inc

Access to resources Recommend Favorite

The return of the prodigal son and the extraordinary development route of antibody TGN1412 ‐ lessons for drug development and clinical pharmacology

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 4, 2015-04 ,pp. : 545-547

John Wiley & Sons Inc

Access to resources Recommend Favorite